This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1979 Jan;15(1):7-10.

doi: 10.1016/0014-2964(79)90198-1.

Decreased half life of cyclophosphamide in patients under continual treatment

M D'Incalci, G Bolis, T Facchinetti, C Mangioni, L Morasca, P Morazzoni, M Salmona

PMID: 421718
DOI: 10.1016/0014-2964(79)90198-1

Decreased half life of cyclophosphamide in patients under continual treatment

M D'Incalci et al. Eur J Cancer (1965). 1979 Jan.

. 1979 Jan;15(1):7-10.

doi: 10.1016/0014-2964(79)90198-1.

Authors

M D'Incalci, G Bolis, T Facchinetti, C Mangioni, L Morasca, P Morazzoni, M Salmona

PMID: 421718
DOI: 10.1016/0014-2964(79)90198-1

No abstract available

PubMed Disclaimer

Similar articles

Pharmacokinetics of cyclophosphamide after prolonged low dose treatment in ovarian cancer patients.
D'Incalci M, Facchinetti T, Bolis G, Mangioni C, Morasca L. D'Incalci M, et al. Eur J Drug Metab Pharmacokinet. 1979;4(2):83-5. doi: 10.1007/BF03189405. Eur J Drug Metab Pharmacokinet. 1979. PMID: 114397
Metabolism of anticancer agents in man.
Adamson RH. Adamson RH. Ann N Y Acad Sci. 1971 Jul 6;179:432-41. doi: 10.1111/j.1749-6632.1971.tb46920.x. Ann N Y Acad Sci. 1971. PMID: 4936777 No abstract available.
Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinoma.
Buckner CD, Briggs R, Clift RA, Fefer A, Funk DD, Glucksberg H, Neiman PE, Storb R, Thomas ED. Buckner CD, et al. Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):697-703. Cancer Chemother Rep. 1974. PMID: 4426048 No abstract available.
Clinical pharmacokinetics of cyclophosphamide.
Grochow LB, Colvin M. Grochow LB, et al. Clin Pharmacokinet. 1979 Sep-Oct;4(5):380-94. doi: 10.2165/00003088-197904050-00004. Clin Pharmacokinet. 1979. PMID: 389529 Review. No abstract available.
The comparative pharmacology of cyclophosphamide and ifosfamide.
Colvin M. Colvin M. Semin Oncol. 1982 Dec;9(4 Suppl 1):2-7. Semin Oncol. 1982. PMID: 6761865 Review. No abstract available.

See all similar articles

Cited by

Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors.
Navid F, Baker SD, McCarville MB, Stewart CF, Billups CA, Wu J, Davidoff AM, Spunt SL, Furman WL, McGregor LM, Hu S, Panetta JC, Turner D, Fofana D, Reddick WE, Leung W, Santana VM. Navid F, et al. Clin Cancer Res. 2013 Jan 1;19(1):236-46. doi: 10.1158/1078-0432.CCR-12-1897. Epub 2012 Nov 8. Clin Cancer Res. 2013. PMID: 23143218 Free PMC article. Clinical Trial.
Ifosfamide clinical pharmacokinetics.
Wagner T. Wagner T. Clin Pharmacokinet. 1994 Jun;26(6):439-56. doi: 10.2165/00003088-199426060-00003. Clin Pharmacokinet. 1994. PMID: 8070218 Review.
Repeated high-dose cyclophosphamide administration in bone marrow transplantation: exposure to activated metabolites.
Schuler U, Ehninger G, Wagner T. Schuler U, et al. Cancer Chemother Pharmacol. 1987;20(3):248-52. doi: 10.1007/BF00570495. Cancer Chemother Pharmacol. 1987. PMID: 3315284
Clinical pharmacokinetics of cyclophosphamide.
Moore MJ. Moore MJ. Clin Pharmacokinet. 1991 Mar;20(3):194-208. doi: 10.2165/00003088-199120030-00002. Clin Pharmacokinet. 1991. PMID: 2025981 Review.
A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide.
Molineux G, Xu C, Hendry J, Testa NG. Molineux G, et al. Cancer Chemother Pharmacol. 1986;18(1):11-6. doi: 10.1007/BF00253055. Cancer Chemother Pharmacol. 1986. PMID: 3757152

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database